{"id":"W2160230582","doi":"10.1086/650697","title":"Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection","year":2010,"lang":"en","type":"article","venue":"The Journal of Infectious Diseases","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":265,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"International AIDS Society","keywords":"Maraviroc; Efavirenz; Zidovudine; Lamivudine; Medicine; CCR5 receptor antagonist; Internal medicine; Viral load; Rilpivirine; Regimen; Virology; Pharmacology; Human immunodeficiency virus (HIV); Virus; Antiretroviral therapy; Viral disease; Hepatitis B virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001903332,0.0006062969,0.001652047,0.0003609543,0.0002592173,0.0006350051,0.000425806,0.0009545293,0.003625752],"category_scores_gemma":[0.002323675,0.000328709,0.001486366,0.0002300202,0.0004750019,0.0004798725,0.0002439875,0.00177487,0.0003140419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004931436,"about_ca_system_score_gemma":0.0006279016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003917173,"about_ca_topic_score_gemma":0.002006928,"domain_scores_codex":[0.998939,0.0006930073,0.00007661321,0.0000757962,0.00008978792,0.0001259222],"domain_scores_gemma":[0.998628,0.0006124614,0.0002905387,0.00005004096,0.00006279817,0.0003561062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9381421,0.003634638,0.002345596,0.0007465178,0.00158039,0.00004716338,0.00008317678,0.0005005392,0.004124893,0.000183073,0.0005474579,0.04806441],"study_design_scores_gemma":[0.6451659,0.3310225,0.01542783,0.000178324,0.002158932,0.0002166457,0.0000524245,0.001207248,0.002096324,0.0003200762,0.002127377,0.00002637377],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876674,0.009249695,0.0002478538,0.0005566296,0.0002971079,0.0003980956,0.0002639251,0.00002191815,0.00129742],"genre_scores_gemma":[0.9949995,0.002467827,0.0005115445,0.0003101585,0.0004619961,0.0002151198,0.0002109087,0.000003944342,0.000819024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003625752,"threshold_uncertainty_score":0.01212937,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009394020614953974,"score_gpt":0.2554735237503099,"score_spread":0.2460795031353559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}